Your browser doesn't support javascript.
loading
TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.
Steurer, Stefan; Mayer, Pascale Sophia; Adam, Meike; Krohn, Antje; Koop, Christina; Ospina-Klinck, Daniel; Tehrani, Ali Attarchi; Simon, Ronald; Tennstedt, Pierre; Graefen, Markus; Wittmer, Corinna; Brors, Benedikt; Plass, Christoph; Korbel, Jan; Weischenfeldt, Joachim; Sauter, Guido; Huland, Hartwig; Tsourlakis, Maria Christina; Minner, Sarah; Schlomm, Thorsten.
Afiliación
  • Steurer S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mayer PS; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Adam M; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Krohn A; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Koop C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Ospina-Klinck D; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tehrani AA; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Simon R; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tennstedt P; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Graefen M; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Wittmer C; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Brors B; Division of Theoretical Bioinformatics, German Cancer Research Center, Heidelberg, Germany.
  • Plass C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany.
  • Korbel J; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Weischenfeldt J; Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.
  • Sauter G; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Huland H; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Tsourlakis MC; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Minner S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schlomm T; Martini-Clinic, Prostate Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: tschlomm@uke.de.
Eur Urol ; 66(6): 978-81, 2014 Dec.
Article en En | MEDLINE | ID: mdl-25015038
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas de Fusión Oncogénica / Transactivadores / Fosfohidrolasa PTEN / Fusión Génica Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2014 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Proteínas de Fusión Oncogénica / Transactivadores / Fosfohidrolasa PTEN / Fusión Génica Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Año: 2014 Tipo del documento: Article País de afiliación: Alemania